Seroepidemiological Investigation of Hepatitis B and C Prevalence and Associated Factors Among People in Custody at Zahedan Central Prison
Open Access
- 15 May 2024
- journal article
- research article
- Published by Maad Rayan Publishing Company in International Journal of Infectious Diseases
- Vol. 27 (6) , 298-304
Abstract
Background: On a global scale, approximately 350 million are affected by hepatitis B, and 71 million by hepatitis C. People in custody face elevated risks for these infections. The prevalence and risk factors in Iranian prisons are insufficiently documented. The principal objective of this study was to ascertain the prevalence of hepatitis B and C, coupled with the identification of pertinent influencing factors, within the confines of Zahedan central prison, situated in the southeastern region of Iran. Methods: In 2019, we conducted an analytical cross-sectional study involving 407 people in custody, using stratified random sampling. To definitively diagnose hepatitis C virus (HCV) infection (P<0.05), a checklist developed by the researchers, along with enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) techniques, were employed. Results: This study comprised 406 participants (96.3% male) with a median age of 32 years (27-38). Approximately 62% were married, and a substantial proportion of the participants had low education levels (47%), unemployment (64%), and belonged to the Baloch ethnicity (64%). The overall prevalence of hepatitis C and B infections was 2.7% and 10.6%, respectively. Tattooing (adjusted odds ratio [AOR]: 2.07, 95% CI: 1.9-4.5) and marriage (AOR: 1.78, 95% CI: 1.05-3.04) were identified as risk factors for hepatitis B. Moreover, hepatitis C showed a statistically significant association with a family history of hepatitis B and C (AOR: 3.31, 95% CI: 3.93-24.64) and intravenous (IV) drug use (AOR: 7.01, 95% CI: 1.52-32.78) according to the multivariable logistic regression analysis. Conclusion: The prevalence of hepatitis B and C was higher among people in custody in Zahedan central prison. Consequently, targeted interventions are vital to address and reduce viral hepatitis burden in custodial settings.Keywords
This publication has 29 references indexed in Scilit:
- An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in IranInternational Journal of Drug Policy, 2021
- Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional studyBMC Infectious Diseases, 2020
- Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015BMC Infectious Diseases, 2018
- Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysisHarm Reduction Journal, 2018
- Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groupsBMC Infectious Diseases, 2018
- The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analysesScientific Reports, 2018
- The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central AsiaThe Lancet, 2016
- Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detaineesThe Lancet, 2016
- Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortBMC Public Health, 2010
- Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysisJournal of Epidemiology and Community Health, 2008